Treatment with cardiac resynchronization therapy was associated with a significant reduction in the risk of HF or death only among internal cardioverter defibrillator-treated patients with a low ( Q@-@ ) S-LVRR score ( hazard ratio = @ ; P < @ ) , but not among those with a higher ( Q@ ) score ( hazard ratio = @ ; P = @ ) .